Moderna’s final analysis of our Phase 3 COVE Study is out (median follow-up 5.3 months): •Against COVID-19: 93.2% •Against severe COVID-19: 98.2% •Against death caused by COVID-19: 100%— Chise 🧬🧫🦠💉 (@sailorrooscout) August 5, 2021 Very nice. Immunity seems to persist well. Delta boosters also make sense, though the vaccine is
August 6, 2021, 10:17 AM · Uncategorized